Indivior, Inc. – FDA EIR, Oct 19, 2017

Record Details

This EIR record concerns Indivior, Inc., with an inspection on October 19, 2017, issued by the Center for Drug Evaluation and Research, covering rx (prescription).

Company: Indivior, Inc.
Inspection date: October 19, 2017
Product type: RX (Prescription)
Office: Center for Drug Evaluation and Research
People: Kent Hoffman (other)
Sunita Shinde (company_representative)
Aaron Blackledge (other)
Karen Hojnowski (company_representative)
Mary DeCosta (company_representative)

View Company Profile

ID · e6bbda3f-b8b4-47d3-9035-4206b000f5c7

Violation Codes2

21 CFR 312.5021 CFR 312

Full citation text and observation details available on the Dashboard.

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Indivior, Inc.

EIR

Indivior, Inc.October 19, 2017

Indivior, Inc. – FDA EIR, Oct 19, 2017

Record Details

This EIR record concerns Indivior, Inc., with an inspection on October 19, 2017, issued by the Center for Drug Evaluation and Research, covering rx (prescription).

Company: Indivior, Inc.
Inspection date: October 19, 2017
Product type: RX (Prescription)
Office: Center for Drug Evaluation and Research
People: Kent Hoffman (other)
Sunita Shinde (company_representative)
Aaron Blackledge (other)
Karen Hojnowski (company_representative)
Mary DeCosta (company_representative)

View Company Profile

ID · e6bbda3f-b8b4-47d3-9035-4206b000f5c7

Violation Codes2

21 CFR 312.5021 CFR 312

Full citation text and observation details available on the Dashboard.

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Indivior, Inc.